Ilika publishes 2025 Annual Report, advancing Goliath and Stereax

Ilika Plc

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology, has given formal notice that the Company’s Annual General Meeting will be held on Tuesday, 23 September 2025 at 2.00 pm (BST) at the offices of Eversheds Sutherland LLP, One Wood Street, London EC2V 7WS.

If you wish to attend the AGM in your capacity as a shareholder, please bring proof of shareholding or, if shares are held through a nominee account, a letter of representation, to facilitate your entry to the Meeting. If you are not planning to attend the meeting and would like someone else to vote for you at the meeting (or any adjournment of the meeting), please complete the form of proxy, which can be accessed using the following link www.investorcentre.co.uk/eproxy

Shareholders are encouraged to appoint the Chairman of the Meeting as their proxy with their voting instructions. Please vote online at www.investorcentre.co.uk/eproxy and enter the Control Number, your Shareholder Reference Number (SRN), and PIN as shown on the Proxy Form.

To be valid, proxy appointments for the Annual General Meeting must be received by the Company’s Registrar, Computershare Investor Services PLC, no later than 2.00 pm (BST) on 19 September 2025.

Posting of Annual Report and AGM Notice

The Company confirms that the Annual Report and Accounts for the year ended 30 April 2025 and the Notice of the 2025 Annual General Meeting (‘AGM’) will be made available shortly to view or download by clicking the links below:

–  Ilika plc Notice of Annual General Meeting: https://www.ilika.com/investors/aim-rule-26

–  Ilika plc Annual Report and Accounts: 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Dr Tom McColm on Ilika: Stereax revenues and Goliath milestones (LON:IKA)

Clean-tech equities specialist Dr Tom McColm reviews Ilika’s interim results, highlighting stable cash levels, the first recurring commercial revenues from Stereax, and continued technical and manufacturing progress on the Goliath battery platform.

Ilika CEO Graeme Purdy on Stereax and Goliath progress (LON:IKA)

Graeme Purdy, CEO of Ilika, outlines progress in manufacturing readiness and early customer shipments for the Stereax miniature solid-state battery, as well as ongoing grant-supported development and customer engagement for the Goliath EV battery programme.

Ilika moves into commercial phase with first Stereax electrode order

Ilika has received its first commercial order for Stereax battery electrodes, marking the start of scaled production for medical device applications.

Ilika plc: First Commercial Revenues Signal Pivotal Shift in Solid-State Battery Journey (Video)

Ilika plc has crossed a commercial milestone with its first regular revenue stream from its Stereax battery line, according to Dr Tom McColm of Morphose Capital. With strong cash reserves, momentum on its Goliath platform, and growing interest from defence sectors, the next 12 months could be transformational.

Ilika Plc: Solid-State Breakthroughs Put Stereax and Goliath in the Spotlight (Video)

Ilika CEO Graeme Purdy shares how the company has shifted from commissioning to customer deliveries of its Stereax batteries — and why its Goliath EV programme is designed to beat the commoditised market with faster charging and extended range.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Search

Search